| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0024115|lung disease |
| Sentences | 1 |
| PubMedID- 23784915 | Conclusion: treatment with aeablc was tolerated without serious toxicity and may be considered in the setting of severe immunosuppression, cancer, and/or hematopoietic stem cell transplantation in patients with difficult-to-treat fungal lung disease. |
Page: 1